Professor G. Paul Amminger MD, PhD, FRANZCP leads a multi-professional team at Orygen engaged in clinical trials research and biomarker studies devoted to testing neuroprotective agents to promote mental health in young people between the ages of 12 and 25 years.
Sign up for our newsletter to get the latest AEPCC news straight to your inbox.